These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9337201)

  • 1. Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation.
    Pakala R; Willerson JT; Benedict CR
    Circulation; 1997 Oct; 96(7):2280-6. PubMed ID: 9337201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of serotonin and thromboxane A2 on endothelial cell proliferation: effect of specific receptor antagonists.
    Pakala R; Benedict CR
    J Lab Clin Med; 1998 Jun; 131(6):527-37. PubMed ID: 9626988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy between thrombin and serotonin in inducing vascular smooth muscle cell proliferation.
    Pakala R; Benedict C
    J Lab Clin Med; 1999 Dec; 134(6):659-67. PubMed ID: 10595795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic interaction between thromboxane A2 and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation.
    Koba S; Pakala R; Watanabe T; Katagiri T; Benedict CR
    Prostaglandins Leukot Essent Fatty Acids; 2000 Dec; 63(6):329-35. PubMed ID: 11133169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin and thromboxane A2 stimulate platelet-derived microparticle-induced smooth muscle cell proliferation.
    Pakala R
    Cardiovasc Radiat Med; 2004; 5(1):20-6. PubMed ID: 15275628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid peroxidation product 4-hydroxy-2-nonenal acts synergistically with serotonin in inducing vascular smooth muscle cell proliferation.
    Watanabe T; Pakala R; Katagiri T; Benedict CR
    Atherosclerosis; 2001 Mar; 155(1):37-44. PubMed ID: 11223424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eicosapentaenoic acid and docosahexaenoic acid selectively attenuate U46619-induced smooth muscle cell proliferation.
    Pakala R; Pakala R; Benedict C
    Lipids; 1999 Sep; 34(9):915-20. PubMed ID: 10574655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopeptin, a somatostatin analogue, inhibits rat coronary artery and aorta smooth muscle cell proliferation induced by the thromboxane A2 mimetic U46619.
    Zhao Y; Foegh ML
    Prostaglandins; 1997 Nov; 54(5):781-93. PubMed ID: 9491208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboxane A2 potentiates thrombin-induced proliferation of coronary artery smooth muscle cells.
    Zucker TP; Bönisch D; Muck S; Weber AA; Bretschneider E; Glusa E; Schrör K
    Adv Exp Med Biol; 1997; 433():387-90. PubMed ID: 9561177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
    Dorn GW; Becker MW; Davis MG
    J Biol Chem; 1992 Dec; 267(34):24897-905. PubMed ID: 1447225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-mediated mitogenic effect of thromboxane A2 in vascular smooth muscle cells.
    Hanasaki K; Nakano T; Arita H
    Biochem Pharmacol; 1990 Dec; 40(11):2535-42. PubMed ID: 2148480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin-induced mitogenesis in coronary artery smooth muscle cells is potentiated by thromboxane A2 and involves upregulation of thromboxane receptor mRNA.
    Zucker TP; Bönisch D; Muck S; Weber AA; Bretschneider E; Glusa E; Schrör K
    Circulation; 1998 Feb; 97(6):589-95. PubMed ID: 9494030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboxane A2 fails to induce proliferation of smooth muscle cells enriched with eicosapentaenoic acid and docosahexaenoic acid.
    Pakala R; Pakala R; Benedict CR
    Prostaglandins Leukot Essent Fatty Acids; 1999 Apr; 60(4):275-81. PubMed ID: 10397410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidylcholine and reactive oxygen species mediate the synergistic effect of mildly oxidized LDL with serotonin on vascular smooth muscle cell proliferation.
    Watanabe T; Pakala R; Koba S; Katagiri T; Benedict CR
    Circulation; 2001 Mar; 103(10):1440-5. PubMed ID: 11245650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of platelet-derived 5-hydroxytryptamine in thromboxane A2-induced aggregation in cat platelets.
    Ogawa T; Sugidachi A; Asai F; Koike H
    Blood Coagul Fibrinolysis; 1998 Apr; 9(3):233-40. PubMed ID: 9663705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
    Kemp BK; Cocks TM
    Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte chemotactic protein 1 amplifies serotonin-induced vascular smooth muscle cell proliferation.
    Watanabe T; Pakala R; Katagiri T; Benedict CR
    J Vasc Res; 2001; 38(4):341-9. PubMed ID: 11455205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation.
    Watanabe T; Pakala R; Katagiri T; Benedict CR
    J Hypertens; 2001 Dec; 19(12):2191-6. PubMed ID: 11725163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
    Shaw LA; Batey AJ; Coker SJ
    Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant contribution of 5-hydroxytryptamine over thromboxane A2 in contractile response of rabbit isolated aortic preparation to thrombin activated platelets.
    Nakanishi H; Matsuoka I; Ono T; Nakahata N
    Res Commun Mol Pathol Pharmacol; 1995 Nov; 90(2):255-67. PubMed ID: 8747793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.